Waltham’s NeuroMetrix announces CES highlights
The Waltham-based NeuroMetrix Inc. has announced a successful CES 2019, a technology event, which took place Jan. 8-11 in Las Vegas. Quell 2.0 was named a CES 2019 Innovation Awards Honoree in the Fitness, Sports and Biotech product category, recognizing the company’s innovative application of AI and neurotechnology to manage chronic pain. NeuroMetrix President and CEO Shai Gozani was a speaker at the Digital Health Summit at CES, focusing on the continued advances in health care. PC Magazine picked Quell 2.0 as one of the “Best Wearables at CES 2019”; The Washington Times named Quell 2.0 a “Technological Option to Opioids”; and Digital Trends included Quell 2.0 in its list of “The best CES 2019 health gadgets.” Jennifer Jolly, technology expert for USA Today, and The Today Show included Quell 2.0 in her TV broadcast from the floor of CES. NeuroMetrix is a commercial stage health-care company combining neurostimulation and digital medicine to address chronic health conditions including chronic pain, sleep disorders and diabetes.